University of California San Francisco
Helen Diller Family Comprehensive Cancer Center
Richard C.K. Jordan, DDS, PhD

Richard C.K. Jordan, DDS, PhD

Professor, Departments of Orofacial Sciences and Pathology, UCSF

Cancer Center Program Memberships

Non-aligned

Education

University of Toronto, D.D.S., 1986, Dentistry
University of Toronto, M.Sc., 1992, Oral Pathology
University of London (UK), Ph.D., 1995, Experimental Pathology


Professional Experience

  • 1986-1987
    Intern; Toronto Western Hospital, Toronto, Canada
  • 1987-1988
    General dental practice; Newmarket, Ontario, Canada
  • 1988-1989
    Resident in anatomic pathology; Toronto Western Hospital, Toronto, Canada
  • 1989-1991
    Resident in Oral Pathology; University of Toronto
  • 1991
    Research Fellow; Canadian Reference Centre for Cancer Pathology, Ottawa, Canada
  • 1992-1995
    Medical Research Council of Canada Research Fellow, U. London, London, UK
  • 1994
    Research Fellow; Department of Haematology; Kanazawa Medical University, Kanazawa, Japan
  • 1995-2000
    Oral Pathologist; Sunnybrook & Women's College Health Sciences Centre, Toronto, Canada
  • 1995-2000
    Assistant Professor; Faculty of Dentistry, University of Toronto
  • 1995-2000
    Assistant Professor, Faculty of Medicine, Dept. of Lab Medicine & Pathobiology, University of Toronto
  • 2000-2001
    Associate Professor, Faculty of Dentistry, University of Toronto
  • 2001-present
    Professor & Vice Chair, Department of Orofacial Sciences & Department of Pathology, UCSF

Honors & Awards

  • 1981
    Senate Scholarship, U. Western Ontario
  • 1985
    Wroblewski Award; Mosby Prize; Murray Cornish Scholarship
  • 1986
    Xi Xsi Phi prize; Deans Honour List
  • 1991
    U. Toronto Open Fellowship; Canadian Fund for Dental Education Award
  • 1994
    International Association of Oral Pathology Award
  • 1995
    International Association for Dental Research prize in Experimental Pathology

Selected Publications

  1. Ko YCK, Varma S, Zhu CF, Zhu SX, Vennam S, Poh CF, Jordan RC, Kong C, Pollack JR, West RB. Gene Expression Profiling of Head and Neck Tumors Identifies FOXP1 and SOX10 Expression as Useful for Distinguishing Ameloblastoma From Basaloid Salivary Gland Tumors. Am J Surg Pathol. 2020 05; 44(5):665-672.
    View on PubMed
  2. Hameed M, Horvai AE, Jordan RCK. Soft Tissue Special Issue: Gnathic Fibro-Osseous Lesions and Osteosarcoma. Head Neck Pathol. 2020 Mar; 14(1):70-82.
    View on PubMed
  3. Wang MZ, Jordan RC. Localized juvenile spongiotic gingival hyperplasia: A report of 27 cases. J Cutan Pathol. 2019 Nov; 46(11):839-843.
    View on PubMed
  4. Hedberg ML, Peyser ND, Bauman JE, Gooding WE, Li H, Bhola NE, Zhu TR, Zeng Y, Brand TM, Kim MO, Jordan RCK, VandenBerg S, Olivas V, Bivona TG, Chiosea SI, Wang L, Mills GB, Johnson JT, Duvvuri U, Ferris RL, Ha P, Johnson DE, Grandis JR. Use of nonsteroidal anti-inflammatory drugs predicts improved patient survival for PIK3CA-altered head and neck cancer. J Exp Med. 2019 02 04; 216(2):419-427.
    View on PubMed
  5. Gale N, Hille J, Jordan RC, Nadal A, Williams MD. Regarding Laryngeal precursor lesions: Interrater and intrarater reliability of histopathological assessment. Laryngoscope. 2019 03; 129(3):E91-E92.
    View on PubMed
  6. Gillison ML, Trotti AM, Harris J, Eisbruch A, Harari PM, Adelstein DJ, Jordan RCK, Zhao W, Sturgis EM, Burtness B, Ridge JA, Ringash J, Galvin J, Yao M, Koyfman SA, Blakaj DM, Razaq MA, Colevas AD, Beitler JJ, Jones CU, Dunlap NE, Seaward SA, Spencer S, Galloway TJ, Phan J, Dignam JJ, Le QT. Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial. Lancet. 2019 01 05; 393(10166):40-50.
    View on PubMed
  7. Ablain J, Xu M, Rothschild H, Jordan RC, Mito JK, Daniels BH, Bell CF, Joseph NM, Wu H, Bastian BC, Zon LI, Yeh I. Human tumor genomics and zebrafish modeling identify SPRED1 loss as a driver of mucosal melanoma. Science. 2018 11 30; 362(6418):1055-1060.
    View on PubMed
  8. Dickson BC, Antonescu CR, Argyris PP, Bilodeau EA, Bullock MJ, Freedman PD, Gnepp DR, Jordan RC, Koutlas IG, Lee CH, Leong I, Merzianu M, Purgina BM, Thompson LDR, Wehrli B, Wright JM, Swanson D, Zhang L, Bishop JA. Ectomesenchymal Chondromyxoid Tumor: A Neoplasm Characterized by Recurrent RREB1-MKL2 Fusions. Am J Surg Pathol. 2018 10; 42(10):1297-1305.
    View on PubMed
  9. Fakhry C, Lacchetti C, Rooper LM, Jordan RC, Rischin D, Sturgis EM, Bell D, Lingen MW, Harichand-Herdt S, Thibo J, Zevallos J, Perez-Ordonez B. Human Papillomavirus Testing in Head and Neck Carcinomas: ASCO Clinical Practice Guideline Endorsement of the College of American Pathologists Guideline. J Clin Oncol. 2018 11 01; 36(31):3152-3161.
    View on PubMed
  10. Cohen JN, Yeh I, Jordan RC, Wolsky RJ, Horvai AE, McCalmont TH, LeBoit PE. Cutaneous Non-Neural Granular Cell Tumors Harbor Recurrent ALK Gene Fusions. Am J Surg Pathol. 2018 09; 42(9):1133-1142.
    View on PubMed
  11. Krings G, Joseph NM, Bean GR, Solomon D, Onodera C, Talevich E, Yeh I, Grenert JP, Hosfield E, Crawford ED, Jordan RC, van Zante A, Zaloudek C, Shin SJ, Chen YY. Genomic profiling of breast secretory carcinomas reveals distinct genetics from other breast cancers and similarity to mammary analog secretory carcinomas. Mod Pathol. 2017 08; 30(8):1086-1099.
    View on PubMed
  12. Ozawa H, Ranaweera RS, Izumchenko E, Makarev E, Zhavoronkov A, Fertig EJ, Howard JD, Markovic A, Bedi A, Ravi R, Perez J, Le QT, Kong CS, Jordan RC, Wang H, Kang H, Quon H, Sidransky D, Chung CH. SMAD4 Loss Is Associated with Cetuximab Resistance and Induction of MAPK/JNK Activation in Head and Neck Cancer Cells. Clin Cancer Res. 2017 Sep 01; 23(17):5162-5175.
    View on PubMed
  13. Weiss EP, Jordan RC, Frese EM, Albert SG, Villareal DT. Effects of Weight Loss on Lean Mass, Strength, Bone, and Aerobic Capacity. Med Sci Sports Exerc. 2017 01; 49(1):206-217.
    View on PubMed
  14. Brand TM, Hartmann S, Bhola NE, Peyser ND, Li H, Zeng Y, Isaacson Wechsler E, Ranall MV, Bandyopadhyay S, Duvvuri U, LaVallee TM, Jordan RCK, Johnson DE, Grandis JR. Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV+ Patients. Clin Cancer Res. 2017 Jun 15; 23(12):3072-3083.
    View on PubMed
  15. Edwards L, Jordan RC. Introduction. Semin Cutan Med Surg. 2015 Dec; 34(4):159-60.
    View on PubMed
  16. Jones KB, Jordan R. White lesions in the oral cavity: clinical presentation, diagnosis, and treatment. Semin Cutan Med Surg. 2015 Dec; 34(4):161-70.
    View on PubMed
  17. Chou A, Schulman JM, Gross AJ, Jordan RC, Ramos DM. Gingival pustules and sterile diffuse sclerosing osteomyelitis as a feature of synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016 May; 121(5):e116-22.
    View on PubMed
  18. Nguyen-Tan PF, Zhang Q, Ang KK, Weber RS, Rosenthal DI, Soulieres D, Kim H, Silverman C, Raben A, Galloway TJ, Fortin A, Gore E, Westra WH, Chung CH, Jordan RC, Gillison ML, List M, Le QT. Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity. J Clin Oncol. 2014 Dec 01; 32(34):3858-66.
    View on PubMed
  19. Schulman JM, Jordan RC. Oral mucus extravasation phenomenon with myxoglobulosis. J Cutan Pathol. 2014 Oct; 41(10):767-70.
    View on PubMed
  20. Chung CH, Zhang Q, Kong CS, Harris J, Fertig EJ, Harari PM, Wang D, Redmond KP, Shenouda G, Trotti A, Raben D, Gillison ML, Jordan RC, Le QT. p16 protein expression and human papillomavirus status as prognostic biomarkers of nonoropharyngeal head and neck squamous cell carcinoma. J Clin Oncol. 2014 Dec 10; 32(35):3930-8.
    View on PubMed

Go to UCSF Profiles, powered by CTSI